PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma
暂无分享,去创建一个
[1] J. Ji,et al. Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis , 2022, Journal for ImmunoTherapy of Cancer.
[2] S. Yao,et al. Multiplexed digital spatial profiling of invasive breast tumors from Black and White women , 2021, Molecular oncology.
[3] Doron Betel,et al. Immunogenicity of a public neoantigen derived from mutated PIK3CA , 2021, bioRxiv.
[4] K. Kurian,et al. Advanced Molecular Characterization Using Digital Spatial Profiling Technology on Immunooncology Targets in Methylated Compared with Unmethylated IDH-Wildtype Glioblastoma , 2021, Journal of oncology.
[5] K. O'Byrne,et al. Highly Multiplexed Digital Spatial Profiling of the Tumor Microenvironment of Head and Neck Squamous Cell Carcinoma Patients , 2021, Frontiers in Oncology.
[6] E. Shin,et al. Distinct tumor immune microenvironments in primary and metastatic lesions in gastric cancer patients , 2020, Scientific Reports.
[7] D. Richard,et al. High-Plex and High-Throughput Digital Spatial Profiling of Non-Small-Cell Lung Cancer (NSCLC) , 2020, medRxiv.
[8] J. W. Kim,et al. PI3K-targeting strategy using alpelisib to enhance the antitumor effect of paclitaxel in human gastric cancer , 2020, Scientific Reports.
[9] Kyoung-Mee Kim,et al. PTEN Protein Loss and Loss-of-Function Mutations in Gastric Cancers: The Relationship with Microsatellite Instability, EBV, HER2, and PD-L1 Expression , 2020, Cancers.
[10] F. Roviello,et al. MSI and EBV Positive Gastric Cancer’s Subgroups and Their Link with Novel Immunotherapy , 2020, Journal of clinical medicine.
[11] Chao Chen,et al. Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy Targets , 2019, bioRxiv.
[12] Joon-Oh Park,et al. Bridging genomics and phenomics of gastric carcinoma , 2019, International journal of cancer.
[13] R. Busuttil,et al. Macrophage spatial heterogeneity in gastric cancer defined by multiplex immunohistochemistry , 2019, Nature Communications.
[14] N. Sivaram,et al. Tumor-intrinsic PIK3CA represses tumor immunogenicity in a model of pancreatic cancer , 2019, The Journal of clinical investigation.
[15] K. Syrigos,et al. High-Plex Predictive Marker Discovery for Melanoma Immunotherapy–Treated Patients Using Digital Spatial Profiling , 2019, Clinical Cancer Research.
[16] H. Rugo,et al. Alpelisib for PIK3CA‐Mutated, Hormone Receptor–Positive Advanced Breast Cancer , 2019, The New England journal of medicine.
[17] W. Haining,et al. PI3K activated tumors evade tumor immunity by promoting an inhibitory myeloid microenvironment , 2019, The Journal of Immunology.
[18] H. Chung,et al. Exon 9 Mutation of PIK3CA Associated With Poor Survival in Patients With Epstein-Barr Virus-associated Gastric Cancer , 2019, AntiCancer Research.
[19] H. Hamana,et al. Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations , 2019, Cancers.
[20] Jingting Jiang,et al. Scoring System for Tumor-Infiltrating Lymphocytes and Its Prognostic Value for Gastric Cancer , 2019, Front. Immunol..
[21] Joon-Oh Park,et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer , 2018, Nature Medicine.
[22] F. Roviello,et al. PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene. , 2018, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.
[23] R. Yantiss,et al. Gastric Carcinomas With Lymphoid Stroma: An Evaluation of the Histopathologic and Molecular Features , 2018, The American journal of surgical pathology.
[24] B. Williams,et al. Understanding immune phenotypes in human gastric disease tissues by multiplexed immunohistochemistry , 2017, Journal of Translational Medicine.
[25] J. Ajani,et al. Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project , 2017, Clinical Cancer Research.
[26] Soyeon Ahn,et al. PIK3CA mutations are associated with increased tumor aggressiveness and Akt activation in gastric cancer. , 2017, Oncotarget.
[27] Kyoung-Mee Kim,et al. Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma , 2016, Gastric Cancer.
[28] Jason G. Jin,et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes , 2015, Nature Medicine.
[29] Steven J. M. Jones,et al. Comprehensive molecular characterization of gastric adenocarcinoma , 2014, Nature.
[30] Li Zhao,et al. Hot-spot mutations in p110α of phosphatidylinositol 3-kinase (PI3K): Differential interactions with the regulatory subunit p85 and with RAS , 2010, Cell cycle.
[31] Li Zhao,et al. Helical domain and kinase domain mutations in p110α of phosphatidylinositol 3-kinase induce gain of function by different mechanisms , 2008, Proceedings of the National Academy of Sciences.
[32] A. Marchetti,et al. Different Prognostic Roles of Mutations in the Helical and Kinase Domains of the PIK3CA Gene in Breast Carcinomas , 2007, Clinical Cancer Research.
[33] Joon-Oh Park,et al. Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial , 2019 .